Stocks and Investing Stocks and Investing
Tue, May 17, 2022

Joanne Wuensch Maintained (ABT) at Strong Buy with Decreased Target to $125 on, May 17th, 2022


Published on 2024-10-27 21:07:38 - WOPRAI, Joanne Wuensch
  Print publication without navigation


Joanne Wuensch of Citigroup, Maintained "Abbott Laboratories" (ABT) at Strong Buy with Decreased Target from $154 to $125 on, May 17th, 2022.

Joanne has made no other calls on ABT in the last 4 months.



There are 10 other peers that have a rating on ABT. Out of the 10 peers that are also analyzing ABT, 1 agrees with Joanne's Rating of Hold. Following is the relevant analyst calls for the last 4 months


  • Danielle Antalffy of "SVB Leerink" Maintained at Hold and Held Target at $140 on, Thursday, April 21st, 2022


These are the ratings of the 9 analyists that currently disagree with Joanne


  • Jayson Bedford of "Raymond James" Maintained at Buy with Decreased Target to $135 on, Thursday, April 21st, 2022
  • Shagun Singh of "RBC Capital" Maintained at Buy with Decreased Target to $143 on, Thursday, April 21st, 2022
  • Vijay Kumar of "Evercore ISI Group" Maintained at Buy and Held Target at $114 on, Sunday, April 10th, 2022
  • Larry Biegelsen of "Wells Fargo" Maintained at Buy with Decreased Target to $150 on, Friday, April 8th, 2022
  • Travis Steed of "B of A Securities" Initiated at Strong Buy and Held Target at $140 on, Wednesday, March 2nd, 2022
  • Cecilia Furlong of "Morgan Stanley" Maintained at Buy with Decreased Target to $151 on, Thursday, January 27th, 2022
  • Matt Miksic of "Credit Suisse" Maintained at Buy with Increased Target to $139 on, Thursday, January 27th, 2022
  • Matthew Taylor of "UBS" Maintained at Strong Buy with Increased Target to $142 on, Thursday, January 27th, 2022
  • Robbie Marcus of "JP Morgan" Maintained at Buy and Held Target at $125 on, Saturday, January 22nd, 2022
Contributing Sources